Burosumab-twza Subcutaneous and Ertugliflozin and sitagliptin
Determining the interaction of Burosumab-twza Subcutaneous and Ertugliflozin and sitagliptin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: burosumab
Brand name: Crysvita
Synonyms: Burosumab
Generic Name: ertugliflozin / sitagliptin
Brand name: Steglujan
Synonyms: Ertugliflozin and Sitagliptin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Burosumab-twza Subcutaneous-Erwinaze
- Burosumab-twza Subcutaneous-Ery-Tab
- Burosumab-twza Subcutaneous-Eryc
- Burosumab-twza Subcutaneous-EryPed
- Burosumab-twza Subcutaneous-EryPed 200
- Burosumab-twza Subcutaneous-Eryped 200 Oral
- Ertugliflozin and sitagliptin-Buspar
- Ertugliflozin and sitagliptin-Buspar Dividose
- Ertugliflozin and sitagliptin-Buspirone
- Ertugliflozin and sitagliptin-Buspirone Hydrochloride
- Ertugliflozin and sitagliptin-Busulfan
- Ertugliflozin and sitagliptin-Busulfan Concentrate Injection